Position in FTH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$577,982
New position
Shares Held
18,337
first reported quarter
Ownership
0.071%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRED ALGER MANAGEMENT, LLC holds $805,760,903 across 54 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,301,919 | $269,139,417 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,302,493 | $126,967,017 | |
| 3 | TWST |
Twist Bioscience Corp
|
558,157 | $57,423,192 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
259,468 | $48,593,167 | |
| 5 | ASND |
Ascendis Pharma A/S
|
171,447 | $45,728,343 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
1,072,830 | $41,518,521 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,081,421 | $38,271,489 | |
| 8 | 1,439,697 | $30,593,561 |
All Filings in FTH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $577,982 | 18,337 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||